Chris Tan
Founding CEO
molecular diagnostic
Angsana Molecular & Diagnostics
Malaysia
Biography
Dr Chris Tan brings more than fifteen years of experience in healthcare, life science and molecular diagnostic sales, marketing, business development and commercial operations across emerging and Fortune 500 companies.Previously, he worked in Thermo Fisher Scientific, the world leader in Life Science and Molecular Diagnostics where he served as the VP, Commercial Operations for APAC, Bioscience Division, representing the Life Science, Molecular Diagnostic, Chemical and Bio processing Business with a revenue responsibility of US$200M (Direct and Channel). Prior to that, he was with Agilent as Business Development Director, Molecular Diagnostics, Asia Pacific. In this role, he successfully formulated and executed the Agilent Asia Pacific Diagnostics’ market development plan including different technology platforms like Microarray, QPCR and LCMS for the launch of the next generation molecular diagnostics business.
Research Interest
Prior to Agilent, Dr Chris Tan was the senior Sales and Marketing Director for Affymetrix where he established Affymetrix to be No 1 market leader in the Asia Pacific for Microarray. He started his career at Parkway Healthcare, the largest premier private hospital group and clinical lab in the Asia Pacific, where he held various positions in Business Development for the clinical lab and hospital operations. A graduate of National University of Singapore (Chemistry), he was awarded MSc and PhD in Biochemistry at University of Newcastle Upon Tyne, UK.